Robust nonradioactive oligonucleotide ligation assay to detect a common point mutation in the CYP2D6 gene causing abnormal drug metabolism.

Hansen, T S

Robust nonradioactive oligonucleotide ligation assay to detect a common point mutation in the CYP2D6 gene causing abnormal drug metabolism. [electronic resource] - Clinical chemistry Mar 1995 - 413-8 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0009-9147


Adenosine Triphosphate--metabolism
Cytochrome P-450 CYP2D6
Cytochrome P-450 Enzyme System--genetics
DNA Ligases--metabolism
DNA Mutational Analysis
Europium
Genotype
Humans
Mixed Function Oxygenases--genetics
Oligonucleotides--metabolism
Pharmaceutical Preparations--metabolism
Point Mutation
Polymerase Chain Reaction
Samarium
Sodium Chloride--pharmacology
Temperature